Literature DB >> 29245059

Proteomic analysis of six- and twelve-month hippocampus and cerebellum in a murine Down syndrome model.

Guido N Vacano1, David S Gibson2, Abdullah Arif Turjoman2, Jeremy W Gawryluk3, Jonathan D Geiger3, Mark Duncan2, David Patterson4.   

Abstract

This study was designed to investigate the brain proteome of the Ts65Dn mouse model of Down syndrome. We profiled the cerebellum and hippocampus proteomes of 6- and 12-month-old trisomic and disomic mice by difference gel electrophoresis. We quantified levels of 2082 protein spots and identified 272 (170 unique UniProt accessions) by mass spectrometry. Four identified proteins are encoded by genes trisomic in the Ts65Dn mouse. Three of these (CRYZL11, EZR, and SOD1) were elevated with p-value <0.05, and 2 proteins encoded by disomic genes (MAPRE3 and PHB) were reduced. Intergel comparisons based on age (6 vs. 12 months) and brain region (cerebellum vs. hippocampus) revealed numerous differences. Specifically, 132 identified proteins were different between age groups, and 141 identified proteins were different between the 2 brain regions. Our results suggest that compensatory mechanisms exist, which ameliorate the effect of trisomy in the Ts65Dn mice. Differences observed during aging may play a role in the accelerated deterioration of learning and memory seen in Ts65Dn mice.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging; Alzheimer's disease; Brain; Down syndrome; Proteome; Ts65Dn

Mesh:

Substances:

Year:  2017        PMID: 29245059      PMCID: PMC5801041          DOI: 10.1016/j.neurobiolaging.2017.11.010

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  95 in total

1.  Segmental trisomy of murine chromosome 16: a new model system for studying Down syndrome.

Authors:  M T Davisson; C Schmidt; E C Akeson
Journal:  Prog Clin Biol Res       Date:  1990

2.  A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions.

Authors:  Tao Yu; Zhongyou Li; Zhengping Jia; Steven J Clapcote; Chunhong Liu; Shaomin Li; Suhail Asrar; Annie Pao; Rongqing Chen; Ni Fan; Sandra Carattini-Rivera; Allison R Bechard; Shoshana Spring; R Mark Henkelman; George Stoica; Sei-Ichi Matsui; Norma J Nowak; John C Roder; Chu Chen; Allan Bradley; Y Eugene Yu
Journal:  Hum Mol Genet       Date:  2010-05-04       Impact factor: 6.150

Review 3.  Chromosomal instability and aneuploidy in cancer: from yeast to man.

Authors:  Sarah J Pfau; Angelika Amon
Journal:  EMBO Rep       Date:  2012-06-01       Impact factor: 8.807

4.  Manifold reduction of moesin in fetal Down syndrome brain.

Authors:  B Lubec; R Weitzdoerfer; M Fountoulakis
Journal:  Biochem Biophys Res Commun       Date:  2001-09-07       Impact factor: 3.575

Review 5.  CRMPs Function in Neurons and Glial Cells: Potential Therapeutic Targets for Neurodegenerative Diseases and CNS Injury.

Authors:  Jun Nagai; Rina Baba; Toshio Ohshima
Journal:  Mol Neurobiol       Date:  2016-06-23       Impact factor: 5.590

6.  Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome.

Authors:  Gina Kirsammer; Sarah Jilani; Hui Liu; Elizabeth Davis; Sandeep Gurbuxani; Michelle M Le Beau; John D Crispino
Journal:  Blood       Date:  2007-09-27       Impact factor: 22.113

7.  Natural gene-expression variation in Down syndrome modulates the outcome of gene-dosage imbalance.

Authors:  Paola Prandini; Samuel Deutsch; Robert Lyle; Maryline Gagnebin; Celine Delucinge Vivier; Mauro Delorenzi; Corinne Gehrig; Patrick Descombes; Stephanie Sherman; Franca Dagna Bricarelli; Chiara Baldo; Antonio Novelli; Bruno Dallapiccola; Stylianos E Antonarakis
Journal:  Am J Hum Genet       Date:  2007-06-20       Impact factor: 11.025

8.  Cytoscape 2.8: new features for data integration and network visualization.

Authors:  Michael E Smoot; Keiichiro Ono; Johannes Ruscheinski; Peng-Liang Wang; Trey Ideker
Journal:  Bioinformatics       Date:  2010-12-12       Impact factor: 6.937

9.  Antagonistic Effects of BACE1 and APH1B-γ-Secretase Control Axonal Guidance by Regulating Growth Cone Collapse.

Authors:  Soraia Barão; Annette Gärtner; Eduardo Leyva-Díaz; Galina Demyanenko; Sebastian Munck; Tine Vanhoutvin; Lujia Zhou; Melitta Schachner; Guillermina López-Bendito; Patricia F Maness; Bart De Strooper
Journal:  Cell Rep       Date:  2015-08-20       Impact factor: 9.423

10.  Gene expression variation in Down's syndrome mice allows prioritization of candidate genes.

Authors:  Marc Sultan; Ilaria Piccini; Daniela Balzereit; Ralf Herwig; Nidhi G Saran; Hans Lehrach; Roger H Reeves; Marie-Laure Yaspo
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

View more
  4 in total

1.  Photobiomodulation reduces gliosis in the basal ganglia of aged mice.

Authors:  Nabil El Massri; Tobias W Weinrich; Jaimie Hoh Kam; Glen Jeffery; John Mitrofanis
Journal:  Neurobiol Aging       Date:  2018-02-26       Impact factor: 4.673

2.  Rapamycin Treatment Ameliorates Age-Related Accumulation of Toxic Metabolic Intermediates in Brains of the Ts65Dn Mouse Model of Down Syndrome and Aging.

Authors:  Nathan Duval; Guido N Vacano; David Patterson
Journal:  Front Aging Neurosci       Date:  2018-09-06       Impact factor: 5.750

3.  DYRK1A Overexpression Alters Cognition and Neural-Related Proteomic Pathways in the Hippocampus That Are Rescued by Green Tea Extract and/or Environmental Enrichment.

Authors:  Ilario De Toma; Mireia Ortega; Patrick Aloy; Eduard Sabidó; Mara Dierssen
Journal:  Front Mol Neurosci       Date:  2019-11-15       Impact factor: 5.639

Review 4.  Intellectual disability: dendritic anomalies and emerging genetic perspectives.

Authors:  Tam T Quach; Harrison J Stratton; Rajesh Khanna; Pappachan E Kolattukudy; Jérome Honnorat; Kathrin Meyer; Anne-Marie Duchemin
Journal:  Acta Neuropathol       Date:  2020-11-23       Impact factor: 17.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.